PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 19.7% in December

PureTech Health plc (OTCMKTS:PTCHF) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 15,100 shares, a drop of 19.7% from the November 30th total of 18,800 shares. Based on an average daily trading volume, of 5,800 shares, the short-interest ratio is presently 2.6 days.

PureTech Health Stock Performance

Shares of PureTech Health stock remained flat at $2.00 on Tuesday. The stock had a trading volume of 30 shares, compared to its average volume of 30,830. PureTech Health has a 1-year low of $1.81 and a 1-year high of $3.00. The stock’s fifty day moving average is $2.06 and its 200 day moving average is $2.10.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.